Clinical Trial

The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

Study acronym: TRACE-1
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is evaluate the effect of pioglitazone compared with placebo on skeletal muscle insulin sensitivity in subjects with cancer and cachexia.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-06-22; most recent amendment 2025-07-01.
Status change: Recruiting → Active, Not Recruiting 2025-02-28
Status change: Not Yet Recruiting → Recruiting 2023-07-18
Trial Details
NCT Number NCT05919147
Lead Sponsor Pennington Biomedical Research Center
Conditions Lung Cancer
Enrollment 24 participants
Start Date 2024-01-03
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-04